Page 44 - Zoo Animal Learning and Training
P. 44

36  Section I: Diagnostics and Planning


           A                                                  B




























           Figure 4.8  Transverse T1‐weighted postcontrast MRI (A) and MRS spectra (TE = 144 ms) (B) of a crossbred dog with presumed glioma in the right frontal
           lobe. The spectra was obtained within the intraaxial mass, clearly seen on the postcontrast image. The spectrum shows an abnormal lactate peak (upper
           arrow), markedly reduced NAA peak (asterisk), and elevation of the choline peak (lower arrow), all typical of a high‐grade glioma.


           spatial resolution (nominal voxel size, 0.45 cm ) MRS imaging to   technique may help to increase the likelihood of a biopsy targeting
                                             3
           grade gliomas determined that there were significantly higher total   the tissue with the highest probability of being malignant, and in
           NAA  values,  lower Cho values,  and  lower  Cho/NAA ratios for   aiding inclusion of all neoplastic tissue while sparing normal tissue
           grade II gliomas compared with grade III tumors [74]. This study   during tumor resection. This same laboratory performed a follow‐
           also determined that chemical shift imaging (CSI) spectra from   up experiment using CNI to compare contrast‐enhancing versus
           grade III astrocytomas had significantly higher maximum Cr values   noncontrast‐enhancing areas associated with gliomas that were
           compared with grade III oligodendrogliomas and grade III oligoas-  hyperintense on T2‐weighted images [86]. This study confirmed
           trocytomas in human patients. This higher maximum Cr concen-  the original data in that the CNIs of biopsy samples not containing
           tration in grade III astrocytomas compared with grade II   tumors  were significantly different from  those obtained within
           oligodendrogliomas is theorized as a result of the increased energy   tumors; tumors were distinguished from nontumor with 0.96 sensi-
           metabolism and increased growth rate of the high‐grade tumors   tivity but only 0.57 specificity. When a CNI of 2.5 was used, the
           [74]. The Cho/PCr‐Cr (phosphocreatine–creatine) ratio is also a   sensitivity and specificity were 0.9 and 0.86, respectively [86]. Half
           reliable  marker  for  tumor  grade  identification.  The  Cho/PCr‐Cr   of the 42 biopsy specimens from contrast‐enhancing tumors that
           ratio was 2.05 ± 0.18 in low‐grade astrocytomas, 2.58 ± 0.11 in   were positively identified as tumor with histopathology came from
           grade III, and 5.1 ± 0.89 in grade IV [66]. These are typical exam-  nonenhancing portions of the lesions. Additionally, 36–45% of the
           ples, where MRS studies have used the ratios of NAA, Cho and Cr   hyperintense lesions that did not enhance on contrast‐enhanced
           to diagnose and differentiate brain lesions. A study by Vuori et al.   T1‐weighted MRI were suspicious for tumor cells, based on the CSI
           [84] showed that the total Cho and Cr values helped differentiate   spectra and CNI of greater than 2.5 [86]. Unfortunately, histopa-
           astrocytomas from oligodendrogliomas and oligoastrocytomas, but   thology was not available for confirmation. This robust tool for dif-
           that none of the metabolite ratios (NAA/Cho, NAA/Cr, Cho/Cr)   ferentiating tumor versus peritumoral edema, necrosis, and normal
           helped differentiate the tumor type. The use of metabolite ratios can   tissue is valuable when using MRS with brain lesions, because of the
           result in loss of metabolic information, since a ratio does not change   high sensitivity to metabolic changes.
           when neither the numerator nor the denominator change, and the   Only a few reports have studied the use of MRS in canine brain
           ratio does not reveal the direction of change. Furthermore, the   tumors [62,87,88]. NAA and Cr were decreased and lactate was
           ratios may not take into account regional and age‐dependent differ-  increased in brain tumors (Figure 4.8) compared with the internal
           ences in metabolite signals. A study by McKnight et al. [85] used   control (normal contralateral side), but Cho exhibited no signifi-
           three‐dimensional CSI to establish a linear model of total Cho ver-  cant difference between neoplastic and normal tissues [62,87].
           sus NAA, in the form of a Gaussian z‐score, the Cho to NAA index
           (CNI) indicating the number of standard deviations of difference   General Assessment of Images from CT and MRI
           between amount of Cho and NAA at a voxel location and mean   Once images have been evaluated for positioning and diagnostic
           values of control spectra. Spectra from normal, edematous, and   quality, they can be critically assessed. Interpretation of images
           necrotic regions will have CNIs close to zero, whereas those   from CT and MRI is similar to that for radiography and based on
           recorded from tumor are elevated. A CNI of 2.0 was used as a   classical Röentgen signs (size, shape, number, alignment, margination)
           threshold to determine tumor versus peritumoral tissue [85]. This   plus signal intensity or tissue attenuation [47]. The comparison of
   39   40   41   42   43   44   45   46   47   48   49